SCHEMBL28807366

SCHEMBL28807366

C=CC(c1ccc(C(C)C)cc1)S(=O)(=O)n1c(C(O)c2ccc(C(=O)OC)cc2)cc2cc(C(F)(F)F)ccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ PPARG P37231 8/20 0.35
▸ PPARA Q07869 7/20 0.35
▸ PPARD Q03181 6/20 0.35
▸ PHGDH O43175 1/20 0.35
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ CA14 Q9ULX7 1/20 0.34
▸ RORC P51449 1/20 0.34
▸ MAPT P10636 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ POLB P06746 1/20 0.32
▸ ERAP2 Q6P179 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27950251 0.86 RORC (0.41) CYP3A4CYP2C19CYP2C9MAPK1PPARG
SCHEMBL12096834 0.81 PPARG (0.46) CYP3A4CYP2C19CYP2C9MAPK1PPARG
SCHEMBL27950350 0.81 PPARG (0.35) CYP3A4CYP2C19CYP2C9MAPK1PPARG
SCHEMBL27936033 0.79 RORC (0.41) CYP3A4CYP2C19CYP2C9MAPK1PPARG
SCHEMBL12096867 0.77 PPARG (0.47) PPARGPPARAPPARDPHGDHCA12
SCHEMBL28775092 0.75 AKR1C3 (0.39) PPARGPPARAPPARDPHGDH
SCHEMBL28809335 0.75 POLB (0.34) CYP3A4CYP2C19CYP2C9MAPK1PPARG
SCHEMBL28947564 0.74 RORC (0.39) PPARGPPARAPPARDCA1CA2
SCHEMBL27833814 0.73 PPARG (0.37) CYP3A4CYP2C9PPARGPPARAPPARD
SCHEMBL27813772 0.73 PPARG (0.36) CYP3A4CYP2C9PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103554006-A Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease FOURNIER LAB SA 2014-02-05 — — CN disclosed
Send feedback